SLP
Simulations Plus, Inc.NASDAQHealthcare$11.99+3.92%ClosedMarket Cap: $241.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.97
P/S
3.19
EV/EBITDA
15.13
DCF Value
$22.63
FCF Yield
9.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.6%
Operating Margin
-89.2%
Net Margin
-81.7%
ROE
-45.5%
ROA
-46.6%
ROIC
-51.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $18.4M | 59.1% | $713.0K | $676.0K | $0.03 | — |
| Q4 2025 | $17.5M | 56.4% | $659.0K | $-681.0K | $-0.03 | — |
| FY 2025 | $79.2M | 58.4% | $-70.7M | $-64.7M | $-3.22 | — |
| Q3 2025 | $20.4M | 64.0% | $-74.2M | $-67.3M | $-3.35 | — |
| Q2 2025 | $22.4M | 58.5% | $2.7M | $3.1M | $0.15 | — |
| Q1 2025 | $18.9M | 54.0% | $126.0K | $206.0K | $0.01 | — |
| Q4 2024 | $18.7M | 36.6% | $-1.2M | $843.0K | $0.04 | $0.06 |
| FY 2024 | $70.0M | 61.6% | $6.1M | $10.0M | $0.49 | $0.24 |
| Q3 2024 | $18.5M | 71.5% | $1.9M | $3.1M | $0.15 | $0.06 |
| Q2 2024 | $18.3M | 72.2% | $4.4M | $4.0M | $0.20 | $0.06 |
| Q1 2024 | $14.5M | 67.9% | $960.0K | $1.9M | $0.10 | $0.06 |
| Q4 2023 | $15.6M | 78.4% | $-284.0K | $534.0K | $0.03 | $0.06 |